CURRENT AFFAIRS | 17 JUNE 2026
In a significant public-health move, the Union Health Ministry has removed cough syrups from the list of medicines that small village stores could sell without a licence. It did so by a deceptively small but consequential change: striking the word “syrup” from Schedule K of the Drugs Rules, notified in the official gazette. The effect is large – cough syrups can now be sold only through licensed pharmacies that employ a pharmacist, rather than over the counter in unlicensed rural shops.
The trigger was a tragedy. At least 22 children died in Madhya Pradesh’s Chhindwara after consuming contaminated cough syrups. Investigators traced the deaths to diethylene glycol and ethylene glycol – toxic industrial solvents that had entered the medicine through cheap, industrial-grade propylene glycol substituted for pharmaceutical-grade material. These are the same poisons implicated in earlier mass child-poisoning incidents linked to Indian-made syrups abroad, which is why the regulatory response has been firm and structural rather than merely punitive.
Under the previous regime, Entry No. 13 of Schedule K allowed villages with a population under 1,000 to sell cough syrups without a sale licence – a relaxation meant to improve rural access to basic medicines. But that same gap let unregulated, potentially adulterated products reach the most vulnerable buyers with no pharmacist to check them. The reform, discussed at the Drug Consultative Committee (DCC) last November, closes that loophole for cough syrups specifically, balancing access against safety. It is a reminder that in drug regulation, the line between a convenience exemption and a public-health hazard can be a single word in a schedule.
India’s drug regulation rests on the Drugs and Cosmetics Act 1940 and the Drugs Rules 1945. Different schedules impose different controls: Schedule H and H1 (prescription-only drugs), Schedule X (narcotic/psychotropic), and Schedule K (drugs and conditions exempted from certain licensing requirements). The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), sets standards and approvals, while licensing and enforcement are largely with state drug controllers – reflecting that public health is a State List subject.
This is a layered Legal and Polity question. It tests the Drugs and Cosmetics Act schedules (H/H1/K/X), the role of CDSCO/DCGI, federalism (health as a State subject), and the constitutional right to health under Article 21. CLAT often pairs a news trigger (Chhindwara deaths) with a static framework (which schedule, which regulator), so being able to map the event onto the statute is exactly the reasoning skill rewarded.
| Action | ‘Syrup’ removed from Schedule K via gazette notification |
| Effect | Cough syrups sold only via licensed pharmacies |
| Trigger | At least 22 children died in Chhindwara, MP |
| Contaminants | Diethylene glycol / ethylene glycol |
| Source of toxin | Industrial-grade propylene glycol |
| Old rule | Schedule K Entry 13: villages under 1,000 could sell without licence |
| Discussed at | Drug Consultative Committee (DCC), last November |
| Governing law | Drugs and Cosmetics Act 1940 + Drugs Rules 1945 |
“K for Keep-it-licensed”: Schedule K = exempted Kategory; remove “syrup” and the exemption is Killed, so syrups now need a pharmacist. Pair it with “H = Hold a prescription, X = eXtra-controlled, K = Konvenience exemption.”
Why This Matters for CLAT: The case shows how administrative law tools – a single gazette amendment to a schedule – can deliver major public-health outcomes. For aspirants it connects statutory interpretation (schedules and exemptions), federal division of powers (health as a State subject), constitutional rights (Article 21 right to health), and consumer protection. It is a model of how a current event becomes a question testing whether you know the statute behind the headline.
Practice Quiz — 10 CLAT-Style Questions
Click an option to reveal the answer and explanation.
